The global Cell Therapy Manufacturing Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Cell Therapy Manufacturing Service is a professional service that covers the entire production process of cell therapy products, from cell collection, separation, culture, expansion to gene modification and quality control. These services support pharmaceutical companies, research institutions and medical institutions to develop and manufacture cell therapy products for the treatment of cancer, genetic diseases, immune diseases, etc.

With the clinical success of cell therapy technologies such as CAR-T cell therapy and stem cell therapy, the market demand for high-quality, large-scale manufacturing of cell therapy products has increased significantly. North America and Europe are currently the main markets, thanks to advanced medical technology and regulatory support, while the Asia-Pacific region, especially China and Japan, is becoming a new growth engine with the rapid development of the biopharmaceutical industry. It is expected that the market will continue to expand in the next few years to meet the growing global demand for cell therapy.

This report delivers a comprehensive overview of the global Cell Therapy Manufacturing Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Therapy Manufacturing Service. The Cell Therapy Manufacturing Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Cell Therapy Manufacturing Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Cell Therapy Manufacturing Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Cell Therapy Manufacturing Service Market Report

Report Metric	Details
Report Name	Cell Therapy Manufacturing Service Market
Segment by Type	Autologous Cell Therapy Manufacturing Services Allogeneic Cell Therapy Manufacturing Services
Segment by Application	Cancer Treatment Regenerative Medicine Genetic Disease Treatment Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Charles River, Lonza, Catalent, Thermo Fisher Scientific, WuXi AppTech, KBI Biopharma, AGC Biologics, GenScript, 3P Biopharmaceuticals, Siegfried, Minaris Regenerative Medicine, Bio-Techne
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cell Therapy Manufacturing Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Cell Therapy Manufacturing Service Market report?

Ans: The main players in the Cell Therapy Manufacturing Service Market are Charles River, Lonza, Catalent, Thermo Fisher Scientific, WuXi AppTech, KBI Biopharma, AGC Biologics, GenScript, 3P Biopharmaceuticals, Siegfried, Minaris Regenerative Medicine, Bio-Techne

What are the Application segmentation covered in the Cell Therapy Manufacturing Service Market report?

Ans: The Applications covered in the Cell Therapy Manufacturing Service Market report are Cancer Treatment, Regenerative Medicine, Genetic Disease Treatment, Others

What are the Type segmentation covered in the Cell Therapy Manufacturing Service Market report?

Ans: The Types covered in the Cell Therapy Manufacturing Service Market report are Autologous Cell Therapy Manufacturing Services, Allogeneic Cell Therapy Manufacturing Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell Therapy Manufacturing Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Autologous Cell Therapy Manufacturing Services

1.2.3 Allogeneic Cell Therapy Manufacturing Services

1.3 Market by Application

1.3.1 Global Cell Therapy Manufacturing Service Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Cancer Treatment

1.3.3 Regenerative Medicine

1.3.4 Genetic Disease Treatment

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell Therapy Manufacturing Service Market Perspective (2021–2032)

2.2 Global Cell Therapy Manufacturing Service Growth Trends by Region

2.2.1 Global Cell Therapy Manufacturing Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Cell Therapy Manufacturing Service Historic Market Size by Region (2021–2026)

2.2.3 Cell Therapy Manufacturing Service Forecasted Market Size by Region (2027–2032)

2.3 Cell Therapy Manufacturing Service Market Dynamics

2.3.1 Cell Therapy Manufacturing Service Industry Trends

2.3.2 Cell Therapy Manufacturing Service Market Drivers

2.3.3 Cell Therapy Manufacturing Service Market Challenges

2.3.4 Cell Therapy Manufacturing Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cell Therapy Manufacturing Service Players by Revenue

3.1.1 Global Top Cell Therapy Manufacturing Service Players by Revenue (2021–2026)

3.1.2 Global Cell Therapy Manufacturing Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Cell Therapy Manufacturing Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Cell Therapy Manufacturing Service Revenue

3.4 Global Cell Therapy Manufacturing Service Market Concentration Ratio

3.4.1 Global Cell Therapy Manufacturing Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Manufacturing Service Revenue in 2025

3.5 Global Key Players of Cell Therapy Manufacturing Service Head Offices and Areas Served

3.6 Global Key Players of Cell Therapy Manufacturing Service, Products and Applications

3.7 Global Key Players of Cell Therapy Manufacturing Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Cell Therapy Manufacturing Service Breakdown Data by Type

4.1 Global Cell Therapy Manufacturing Service Historic Market Size by Type (2021–2026)

4.2 Global Cell Therapy Manufacturing Service Forecasted Market Size by Type (2027–2032)

5 Cell Therapy Manufacturing Service Breakdown Data by Application

5.1 Global Cell Therapy Manufacturing Service Historic Market Size by Application (2021–2026)

5.2 Global Cell Therapy Manufacturing Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Cell Therapy Manufacturing Service Market Size (2021–2032)

6.2 North America Cell Therapy Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Cell Therapy Manufacturing Service Market Size by Country (2021–2026)

6.4 North America Cell Therapy Manufacturing Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cell Therapy Manufacturing Service Market Size (2021–2032)

7.2 Europe Cell Therapy Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Cell Therapy Manufacturing Service Market Size by Country (2021–2026)

7.4 Europe Cell Therapy Manufacturing Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Cell Therapy Manufacturing Service Market Size (2021–2032)

8.2 Asia-Pacific Cell Therapy Manufacturing Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Cell Therapy Manufacturing Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Cell Therapy Manufacturing Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Cell Therapy Manufacturing Service Market Size (2021–2032)

9.2 Latin America Cell Therapy Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Cell Therapy Manufacturing Service Market Size by Country (2021–2026)

9.4 Latin America Cell Therapy Manufacturing Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cell Therapy Manufacturing Service Market Size (2021–2032)

10.2 Middle East & Africa Cell Therapy Manufacturing Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Cell Therapy Manufacturing Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Cell Therapy Manufacturing Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Charles River

11.1.1 Charles River Company Details

11.1.2 Charles River Business Overview

11.1.3 Charles River Cell Therapy Manufacturing Service Introduction

11.1.4 Charles River Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.1.5 Charles River Recent Development

11.2 Lonza

11.2.1 Lonza Company Details

11.2.2 Lonza Business Overview

11.2.3 Lonza Cell Therapy Manufacturing Service Introduction

11.2.4 Lonza Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.2.5 Lonza Recent Development

11.3 Catalent

11.3.1 Catalent Company Details

11.3.2 Catalent Business Overview

11.3.3 Catalent Cell Therapy Manufacturing Service Introduction

11.3.4 Catalent Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.3.5 Catalent Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Cell Therapy Manufacturing Service Introduction

11.4.4 Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 WuXi AppTech

11.5.1 WuXi AppTech Company Details

11.5.2 WuXi AppTech Business Overview

11.5.3 WuXi AppTech Cell Therapy Manufacturing Service Introduction

11.5.4 WuXi AppTech Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.5.5 WuXi AppTech Recent Development

11.6 KBI Biopharma

11.6.1 KBI Biopharma Company Details

11.6.2 KBI Biopharma Business Overview

11.6.3 KBI Biopharma Cell Therapy Manufacturing Service Introduction

11.6.4 KBI Biopharma Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.6.5 KBI Biopharma Recent Development

11.7 AGC Biologics

11.7.1 AGC Biologics Company Details

11.7.2 AGC Biologics Business Overview

11.7.3 AGC Biologics Cell Therapy Manufacturing Service Introduction

11.7.4 AGC Biologics Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.7.5 AGC Biologics Recent Development

11.8 GenScript

11.8.1 GenScript Company Details

11.8.2 GenScript Business Overview

11.8.3 GenScript Cell Therapy Manufacturing Service Introduction

11.8.4 GenScript Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.8.5 GenScript Recent Development

11.9 3P Biopharmaceuticals

11.9.1 3P Biopharmaceuticals Company Details

11.9.2 3P Biopharmaceuticals Business Overview

11.9.3 3P Biopharmaceuticals Cell Therapy Manufacturing Service Introduction

11.9.4 3P Biopharmaceuticals Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.9.5 3P Biopharmaceuticals Recent Development

11.10 Siegfried

11.10.1 Siegfried Company Details

11.10.2 Siegfried Business Overview

11.10.3 Siegfried Cell Therapy Manufacturing Service Introduction

11.10.4 Siegfried Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.10.5 Siegfried Recent Development

11.11 Minaris Regenerative Medicine

11.11.1 Minaris Regenerative Medicine Company Details

11.11.2 Minaris Regenerative Medicine Business Overview

11.11.3 Minaris Regenerative Medicine Cell Therapy Manufacturing Service Introduction

11.11.4 Minaris Regenerative Medicine Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.11.5 Minaris Regenerative Medicine Recent Development

11.12 Bio-Techne

11.12.1 Bio-Techne Company Details

11.12.2 Bio-Techne Business Overview

11.12.3 Bio-Techne Cell Therapy Manufacturing Service Introduction

11.12.4 Bio-Techne Revenue in Cell Therapy Manufacturing Service Business (2021–2026)

11.12.5 Bio-Techne Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Charles River

Lonza

Catalent

Thermo Fisher Scientific

3P Biopharmaceuticals

Siegfried

Minaris Regenerative Medicine

Bio-Techne

List of Tables

Table 1. Global Cell Therapy Manufacturing Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Autologous Cell Therapy Manufacturing Services

Table 3. Key Players of Allogeneic Cell Therapy Manufacturing Services

Table 4. Global Cell Therapy Manufacturing Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Cell Therapy Manufacturing Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Cell Therapy Manufacturing Service Market Size by Region (US$ Million), 2021–2026

Table 7. Global Cell Therapy Manufacturing Service Market Share by Region (2021–2026)

Table 8. Global Cell Therapy Manufacturing Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Cell Therapy Manufacturing Service Market Share by Region (2027–2032)

Table 10. Cell Therapy Manufacturing Service Market Trends

Table 11. Cell Therapy Manufacturing Service Market Drivers

Table 12. Cell Therapy Manufacturing Service Market Challenges

Table 13. Cell Therapy Manufacturing Service Market Restraints

Table 14. Global Cell Therapy Manufacturing Service Revenue by Players (US$ Million), 2021–2026

Table 15. Global Cell Therapy Manufacturing Service Market Share by Players (2021–2026)

Table 16. Global Top Cell Therapy Manufacturing Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell Therapy Manufacturing Service Revenue, 2025

Table 17. Ranking of Global Top Cell Therapy Manufacturing Service Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Cell Therapy Manufacturing Service Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Cell Therapy Manufacturing Service, Headquarters and Area Served

Table 20. Global Key Players of Cell Therapy Manufacturing Service, Products and Applications

Table 21. Global Key Players of Cell Therapy Manufacturing Service, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Cell Therapy Manufacturing Service Market Size by Type (US$ Million), 2021–2026

Table 24. Global Cell Therapy Manufacturing Service Revenue Market Share by Type (2021–2026)

Table 25. Global Cell Therapy Manufacturing Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Cell Therapy Manufacturing Service Revenue Market Share by Type (2027–2032)

Table 27. Global Cell Therapy Manufacturing Service Market Size by Application (US$ Million), 2021–2026

Table 28. Global Cell Therapy Manufacturing Service Revenue Market Share by Application (2021–2026)

Table 29. Global Cell Therapy Manufacturing Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Cell Therapy Manufacturing Service Revenue Market Share by Application (2027–2032)

Table 31. North America Cell Therapy Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Cell Therapy Manufacturing Service Market Size by Country (US$ Million), 2021–2026

Table 33. North America Cell Therapy Manufacturing Service Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Cell Therapy Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Cell Therapy Manufacturing Service Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Cell Therapy Manufacturing Service Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Cell Therapy Manufacturing Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Cell Therapy Manufacturing Service Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Cell Therapy Manufacturing Service Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Cell Therapy Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Cell Therapy Manufacturing Service Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Cell Therapy Manufacturing Service Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Cell Therapy Manufacturing Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Cell Therapy Manufacturing Service Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Cell Therapy Manufacturing Service Market Size by Country (US$ Million), 2027–2032

Table 46. Charles River Company Details

Table 47. Charles River Business Overview

Table 48. Charles River Cell Therapy Manufacturing Service Product

Table 49. Charles River Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 50. Charles River Recent Development

Table 51. Lonza Company Details

Table 52. Lonza Business Overview

Table 53. Lonza Cell Therapy Manufacturing Service Product

Table 54. Lonza Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 55. Lonza Recent Development

Table 56. Catalent Company Details

Table 57. Catalent Business Overview

Table 58. Catalent Cell Therapy Manufacturing Service Product

Table 59. Catalent Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 60. Catalent Recent Development

Table 61. Thermo Fisher Scientific Company Details

Table 62. Thermo Fisher Scientific Business Overview

Table 63. Thermo Fisher Scientific Cell Therapy Manufacturing Service Product

Table 64. Thermo Fisher Scientific Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 65. Thermo Fisher Scientific Recent Development

Table 66. WuXi AppTech Company Details

Table 67. WuXi AppTech Business Overview

Table 68. WuXi AppTech Cell Therapy Manufacturing Service Product

Table 69. WuXi AppTech Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 70. WuXi AppTech Recent Development

Table 71. KBI Biopharma Company Details

Table 72. KBI Biopharma Business Overview

Table 73. KBI Biopharma Cell Therapy Manufacturing Service Product

Table 74. KBI Biopharma Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 75. KBI Biopharma Recent Development

Table 76. AGC Biologics Company Details

Table 77. AGC Biologics Business Overview

Table 78. AGC Biologics Cell Therapy Manufacturing Service Product

Table 79. AGC Biologics Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 80. AGC Biologics Recent Development

Table 81. GenScript Company Details

Table 82. GenScript Business Overview

Table 83. GenScript Cell Therapy Manufacturing Service Product

Table 84. GenScript Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 85. GenScript Recent Development

Table 86. 3P Biopharmaceuticals Company Details

Table 87. 3P Biopharmaceuticals Business Overview

Table 88. 3P Biopharmaceuticals Cell Therapy Manufacturing Service Product

Table 89. 3P Biopharmaceuticals Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 90. 3P Biopharmaceuticals Recent Development

Table 91. Siegfried Company Details

Table 92. Siegfried Business Overview

Table 93. Siegfried Cell Therapy Manufacturing Service Product

Table 94. Siegfried Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 95. Siegfried Recent Development

Table 96. Minaris Regenerative Medicine Company Details

Table 97. Minaris Regenerative Medicine Business Overview

Table 98. Minaris Regenerative Medicine Cell Therapy Manufacturing Service Product

Table 99. Minaris Regenerative Medicine Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 100. Minaris Regenerative Medicine Recent Development

Table 101. Bio-Techne Company Details

Table 102. Bio-Techne Business Overview

Table 103. Bio-Techne Cell Therapy Manufacturing Service Product

Table 104. Bio-Techne Revenue in Cell Therapy Manufacturing Service Business (US$ Million), 2021–2026

Table 105. Bio-Techne Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Cell Therapy Manufacturing Service Picture

Figure 2. Global Cell Therapy Manufacturing Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Cell Therapy Manufacturing Service Market Share by Type: 2025 vs 2032

Figure 4. Autologous Cell Therapy Manufacturing Services Features

Figure 5. Allogeneic Cell Therapy Manufacturing Services Features

Figure 6. Global Cell Therapy Manufacturing Service Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Cell Therapy Manufacturing Service Market Share by Application: 2025 vs 2032

Figure 8. Cancer Treatment Case Studies

Figure 9. Regenerative Medicine Case Studies

Figure 10. Genetic Disease Treatment Case Studies

Figure 11. Others Case Studies

Figure 12. Cell Therapy Manufacturing Service Report Years Considered

Figure 13. Global Cell Therapy Manufacturing Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Cell Therapy Manufacturing Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Cell Therapy Manufacturing Service Market Share by Region: 2025 vs 2032

Figure 16. Global Cell Therapy Manufacturing Service Market Share by Players in 2025

Figure 17. Global Cell Therapy Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Cell Therapy Manufacturing Service Revenue in 2025

Figure 19. North America Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Cell Therapy Manufacturing Service Market Share by Country (2021–2032)

Figure 21. United States Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Cell Therapy Manufacturing Service Market Share by Country (2021–2032)

Figure 25. Germany Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Cell Therapy Manufacturing Service Market Share by Region (2021–2032)

Figure 33. China Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Cell Therapy Manufacturing Service Market Share by Country (2021–2032)

Figure 41. Mexico Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Cell Therapy Manufacturing Service Market Share by Country (2021–2032)

Figure 45. Israel Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Cell Therapy Manufacturing Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Charles River Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 49. Lonza Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 50. Catalent Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 52. WuXi AppTech Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 53. KBI Biopharma Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 54. AGC Biologics Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 55. GenScript Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 56. 3P Biopharmaceuticals Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 57. Siegfried Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 58. Minaris Regenerative Medicine Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 59. Bio-Techne Revenue Growth Rate in Cell Therapy Manufacturing Service Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions